Show simple item record

Phenelzine produces subsensitivity to nicotine

dc.contributor.authorDilsaver, Steven C.en_US
dc.contributor.authorHariharan, Meenatshisundananen_US
dc.contributor.authorDavidson, Robin K.en_US
dc.date.accessioned2006-04-10T15:37:32Z
dc.date.available2006-04-10T15:37:32Z
dc.date.issued1993-09en_US
dc.identifier.citationDilsaver, Steven C., Hariharan, Meenatshisundanan, Davidson, Robin K. (1993/09)."Phenelzine produces subsensitivity to nicotine." Progress in Neuro-Psychopharmacology and Biological Psychiatry 17(5): 847-860. <http://hdl.handle.net/2027.42/30616>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6TBR-475CCTV-CY/2/c603d7facad5c3c2b4a2254e1288dec1en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/30616
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8255990&dopt=citationen_US
dc.description.abstractDilsaver, Steven C., Meenatshisundanan Hariharan, Robin K. Davidson: Phenelzine Produces Subsensitivity to Nicotine. Prog. Neuro-Psychopharmacol. &amp; Biol. Psychiat. 1993, 17(5): 847-860. 1. 1. The authors attempted to detect a possible effect of treatment with phenelzine on a physiological response to nicotine in the rat.2. 2. Positive findings in an animal model suggest the feasibility of more complicated experiments in animals and the possibility of studies involving human subjects.3. 3. Treatment of Sprague Dawley rats (n = 10) with phenelzine sulfate (15.0 mg/kg ip) every 48 hours for 14 days was associated with a 73.3% decrease in the hypothermic response to nicotine.4. 4. Treatment with phenelzine did not enhance the rate of elimination of nicotine.5. 5. The authors discuss a possible relationship between changes in nicotinic mechanisms and the therapeutic actions of drugs used to treat affective illness.en_US
dc.format.extent892509 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titlePhenelzine produces subsensitivity to nicotineen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychiatry and Mental Health Research University of Michigan, U.S.A.en_US
dc.contributor.affiliationumDepartment of Psychiatry and Mental Health Research University of Michigan, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Psychiatry and Behavioral Sciences, School of Medicine, University of Texas, Houston Clinical Research Unit Harris County Psychiatric Center Houston, Texas, U.S.A.en_US
dc.identifier.pmid8255990en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/30616/1/0000256.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0278-5846(93)90065-Zen_US
dc.identifier.sourceProgress in Neuro-Psychopharmacology and Biological Psychiatryen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.